ctrl K

Watchlist Price Alert

Taysha Gene Therapies Inc... (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

2.21

-0.25 (-10.16%)

At close: May 06, 2025, 11:56 AM

Taysha Gene Therapies Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	8.33M	15.45M	2.5M	n/a	n/a	n/a
Cost of Revenue	1.25M	n/a	2.49M	492K	9K	n/a
Gross Profit	7.09M	15.45M	15K	-492K	-9K	n/a
Operating Income	-91.46M	-72.44M	-162.45M	-173.27M	-43M	-1.11M
Interest Income	6.94M	3.57M	249K	172K	49K	n/a
Pretax Income	-89.3M	-111.57M	-166.01M	-174.52M	-60.01M	-1.11M
Net Income	-89.3M	-111.57M	-169.58M	-175.46M	-43M	-1.11M
Selling & General & Admin	28.95M	30.05M	37.36M	41.32M	11.11M	128K
Research & Development	66M	56.78M	91.17M	131.94M	31.89M	987K
Other Expenses	4.84M	1.06M	-18K	n/a	-17.03M	n/a
Operating Expenses	99.79M	87.89M	128.53M	173.27M	43M	1.11M
Interest Expense	102K	5M	3.8M	1.43M	28K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	-384K
Cost & Expenses	99.79M	87.89M	128.53M	173.27M	43M	1.11M
Income Tax Expense	n/a	n/a	3.57M	936K	-17.01M	-4.46M
Shares Outstanding (Basic)	250.13M	232.24M	175.81M	150.6M	70.66M	147.97M
Shares Outstanding (Diluted)	250.13M	232.24M	175.81M	150.6M	70.66M	147.97M
EPS (Basic)	-0.36	-0.96	-3.86	-4.66	-2.43	-0.03
EPS (Diluted)	-0.36	-0.96	-3.86	-4.66	-2.43	-0.03
EBITDA	-87.95M	-105.2M	-159.73M	-172.78M	-42.99M	n/a
EBIT	-89.2M	-106.57M	-162.22M	-173.27M	-59.98M	-4.46M
Depreciation & Amortization	1.25M	1.37M	2.49M	492K	9K	4.46M